SHANNA KROGMAN: Open Payments
NPI 1285288795 · CLINTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 36 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $28 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $208 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Lilly USA, LLC | 3 | $60 |
| PFIZER INC. | 3 | $52 |
| Dexcom, Inc. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Amgen Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
| Orexo US, Inc. | 1 | $17 |
Products named: VRAYLAR, BREZTRI, MOUNJARO, Dexcom G6 Transmitter, QULIPTA, JARDIANCE, ELIQUIS, NURTEC ODT.
Industry payments across IA — which companies pay providers there.
